Nyt studie med Ofatumumab:
-
Nyt studie med Ofatumumab:
The goal of this clinical research study is to find out if ofatumumab can control Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) that is left after chemotherapy or chemoimmunotherapy. The safety of the drug will also be studied.
Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy
This study is not yet open for participant recruitment.
Verified by M.D. Anderson Cancer Center, December 2010First Received: December 9, 2010 Last Updated: December 10, 2010
http://clinicaltrials.gov/ct2/show/NCT01258933?term=ofatumumab&rank=24
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind